http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3560504-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6f6a6487902840957ea22664781405d8 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-54 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-54 |
filingDate | 1968-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 1971-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_243aaa2493903bc621c5df5ba700fb6c |
publicationDate | 1971-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-3560504-A |
titleOfInvention | Virostatically effective substituted 3-alkenyl-5-ethyl uracil compounds |
abstract | HIGHLY EFFECTIVE VIROSTATIC AGENTS ARE SUBSTITUTED 5-ETHYL URACIL COMPOUNDS WHICH HAVE ALKENYL WITH 3 TO 6 CARBON ATOMS IN 3-POSITION AND MAY BE SUBSTITUTED IN 1POSITION BY ALKYL WITH 1 TO 4 CARBON ATOMS, CYCLOALKYL, ARYL, OR ARALKYL AND IN 4-POSITION BY HALOGEN. EXAMPLES OF SUCH COMPOUNDS ARE 1,5-DIETHYL-3-ALLYL-4-CHLORO URACIL, 1-METHYL-3-ALLYL OR CROTYL-4-CHLORO-5-ETHYL URACILS, 1METHYL OR ETHYL-3-ALLYL OR CROTYL-5-ETHYL URACILS. THEY ARE PREFERABLY OBTAINED BY ALKENYLATION IN 3-POSITION OF THE CORRESPONDING 5-ETHYL URACIL COMPOUNDS WHICH HAVE IN 3-POSITION HYDROGEN. THEY ARE PREFERABLY TOPICALLY APPLIED TO THE VIRUS-AFFECTED AREAS OF THE BODY IN THE FORM OF SOLUTIONS, OINTMENTS, POWDERS, SPRAYS, OR THE LIKE WHICH CONTAIN BETWEEN ABOUT 0.5% AND ABOUT 50% THEREOF. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5914399-A |
priorityDate | 1968-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 39.